Results 91 to 100 of about 1,761 (189)

Improving Adult Immunization Compliance

, 2022
Background: Vaccines are an integral part of medicine and public health today responsible for decreasing the incidence, prevalence, morbidity, and mortality of vaccine-preventable diseases (Ventola, 2016).
Petrykowski, Nicole
core  

An ODE-based mixed modelling approach for B- and T-cell dynamics induced by Varicella-Zoster Virus vaccines in adults shows higher T-cell proliferation with Shingrix than with Varilrix

, 2019
: Clinical trials covering the immunogenicity of a vaccine aim to study the longitudinal dynamics of certain immune cells after vaccination. The corresponding immunogenicity datasets are mainly analyzed by the use of statistical (mixed effects) models ...
Ogunjimi, Benson, van Damme, Pierre, Beutels, Philippe, Keersmaekers, Nina, Hens, Niel   +4 more
core   +1 more source

A Patient-Facing Dashboard to Promote Shingrix™ Vaccination in a Continuing Care Retirement Community: A Quality Improvement Project

, 2021
BACKGROUND: Shingles is considered one of the most significant vaccine-preventable diseases of older adults based on its morbidity and public health burden, which increase drastically with age.
Stewart, Emily S
core  

Herpes zoster ophthalmicus despite shingrix immunization

Advances in Ophthalmology & Visual System
Background: Herpes zoster ophthalmicus (HZO) is a reactivation of the varicella-zoster virus causing serious ocular and systemic complications, particularly in individuals with declining immunity. Case report: A 74-year-old male with a history of various chronic conditions was referred to an eye clinic due to herpes zoster affecting his right forehead
Len V Koh, Chad E Gosnell, Allison C Makadia, Virginia O Bice, Kyle P Criswell   +4 more
openaire   +1 more source

The Shingrix Vaccine: Information for Patients About Current Recommendations & the National Shortage

, 2018
In the US, herpes zoster and related complications have been estimated to result in 1.3 billion dollars of medical costs alone annually. In order to combat this significant public health burden, efforts have been made to vaccinate susceptible populations
Shah, Purvi
core  

Comparison of the Immunogenicity of the LZ901 Vaccine and HZ/su Vaccine in a Mouse Model

Vaccines
Herpes zoster (HZ) is an infectious disease caused by the reactivation of varicella zoster virus (VZV), with 68% of cases occurring in adults over 50 years of age.
Yaru Quan, Chunxia Liu, Xu Lu, Xi Kong, Shuai Yang, Jian Kong, Wenyan Wan, Kaiqin Wang, Kangwei Xu, Ling Peng   +9 more
doaj   +1 more source

Recombinant Zoster Vaccine (Shingrix) Knowledge And Practices of Primary Care Providers in Mississippi

, 2019
The purpose of this study was to determine Mississippi primary care providers\u27 (PCP) knowledge and practices of the Centers for Disease Control and Prevention\u27s (CDC) Advisory Committee on Immunization Practices (ACIP) recommendations for ...
Word, Kimberly, Gault, Leigh, Lee, Mackinzie, Brown, Casie   +3 more
core  

Intramuscular Shingrix vaccination infographic

Recombinant Zoster Vaccine (Shingrix)Using Shingrix vaccineKNOW THE SITE. GET IT RIGHT!Store and Prepare the Vaccine\u2022 Store Shingrix vaccine (recombinant zoster vaccine) AND adjuvanted diluent in the refrigerator between 2\ub0C and 8\ub0C (36\ub0F ...

core  

Potent and long-lasting humoral and cellular immunity against varicella zoster virus induced by mRNA-LNP vaccine

npj Vaccines
Varicella zoster virus (VZV) is a highly contagious human herpes virus responsible for causing chickenpox (varicella) and shingles (herpes zoster). Despite the approval of a highly effective vaccine, Shingrix®, the global incidence of herpes zoster is ...
Anannya Bhattacharya, Lonzaric Jan, Olga Burlak, Jilong Li, Ghanshyam Upadhyay, Katherine Williams, Jinhui Dong, Harrison Rohrer, Michelle Pynn, Andrew Simon, Nathan Kuhlmann, Sergei Pustylnikov, Mariane B. Melo, Antu K. Dey   +13 more
doaj   +1 more source

Αξιολόγηση του εμβολιασμού για τον έρπητα ζωστήρα στους ηλικιωμένους

, 2022
Εισαγωγή: Ο κίνδυνος ανάπτυξης έρπητα ζωστήρα αυξάνεται με την ηλικία καθώς σχετίζεται με μείωση της κυτταρικής ανοσίας.Ο εμβολιασμός των ηλικιωμένων αποτελεί τη μοναδική μέθοδο πρόληψης.
Σφουγγάρη Μαρία, Sfouggari Maria   +1 more
core